V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003304 | 210006664 | 1.65 | 116.2 | Palliative (P) | null | 2019-01-17 | FEC 100 | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100561238 |
| 210003305 | 210006665 | 1.58 | 59 | Neo-adjuvant (N) | 2019-07-21 | 2019-08-06 | EC | null | N | EC | 100432458 |
| 210003307 | 210006666 | 1.57 | 103.7 | Neo-adjuvant (N) | null | 2018-12-31 | null | 02 | N | EVEROLIMUS | 100133164 |
| 210003308 | 210006667 | 1.75 | 0 | Palliative (P) | 2019-07-09 | 2019-07-09 | Trial Unspecified | null | N | CARBOPLATIN + GEMCITABINE | 101739553 |
| 210003311 | 210006670 | 1.69 | 109.2 | Palliative (P) | 2019-10-08 | 2019-10-16 | FEC 60 or 75 | 02 | N | FEC | 101800626 |
| 210003312 | 210006671 | null | null | null | null | 2017-08-17 | null | null | null | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100032054 |
| 210003314 | 210006673 | 1.68 | 71.4 | Adjuvant (A) | 2020-01-23 | 2020-01-26 | Cyclophosphamide + Docetaxel | null | N | ROSCO TRIAL | 100408927 |
| 210003315 | 210006674 | 1.67 | 83.7 | Neo-adjuvant (N) | 2019-05-12 | 2019-05-12 | null | 02 | N | CARBOPLATIN | 101120071 |
| 210003316 | 210006675 | 1.65 | null | Palliative (P) | 2016-04-20 | 2016-04-30 | null | 01 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100898946 |
| 210003326 | 210006682 | null | 57.2 | null | 2017-04-18 | 2017-04-27 | FEC 60 or 75 | N | null | FEC | 101671812 |
| 210003327 | 210006683 | null | null | Palliative (P) | null | 2019-07-01 | Letrozole + Palbociclib | null | N | CARBOPLATIN + GEMCITABINE | 100199383 |
| 210003328 | 210006684 | 1.62 | 84.4 | null | null | 2019-05-06 | FEC 60 or 75 | null | null | FEC | 101346546 |
| 210003330 | 210006686 | 1.6 | 78.1 | Palliative (P) | 2018-04-04 | 2018-06-27 | FEC + DOCETAXEL | 02 | N | FEC + DOCETAXEL | 101288731 |
| 210003332 | 210006688 | null | null | null | 2019-06-22 | 2019-06-23 | Capecitabine + Oxaliplatin 14day | 02 | null | PALBOCICLIB | 101530185 |
| 210003333 | 210006689 | 1.54 | 71.3 | Adjuvant (A) | 2019-08-29 | 2019-09-21 | Paclitaxel+Trastuzumab wkly Maint | N | N | ALECTINIB | 100273998 |
| 210003334 | 210006690 | 1.6 | 56 | Neo-adjuvant (N) | 2018-12-01 | 2018-12-01 | FEC 60 or 75 | 02 | N | FEC | 100478602 |
| 210003339 | 210006694 | null | null | null | 2016-11-28 | 2016-12-08 | Paclitaxel+Trastuzumab wkly Maint | 02 | null | PACLITAXEL + TRASTUZUMAB | 101171326 |
| 210003340 | 210006695 | 1.61 | 68.4 | Palliative (P) | null | 2021-06-18 | CARBOPLATIN + PACLITAXEL | null | N | CARBOPLATIN | 101216382 |
| 210003345 | 210006700 | 1.61 | 95 | Neo-adjuvant (N) | 2014-07-09 | 2014-07-17 | FEC 60 or 75 | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101358621 |
| 210003348 | 210006702 | null | null | null | 2017-09-09 | 2017-09-24 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN + PACLITAXEL | 100405639 |
| 210003349 | 210006703 | 1.6 | 135.7 | Palliative (P) | 2016-05-24 | 2016-05-25 | null | null | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100259992 |
| 210003350 | 210006704 | null | 68 | null | null | 2018-12-18 | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL + Pertuzumab + Trastuzumab | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100164822 |
| 210003351 | 210006705 | null | null | null | null | 2019-11-25 | null | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101572905 |
| 210003354 | 210006708 | 1.64 | 77 | Neo-adjuvant (N) | null | 2016-08-10 | PERTUZUMAB | N | N | LETROZOLE + PALBOCICLIB | 101398167 |
| 210003355 | 210006709 | 1.63 | 42.9 | Palliative (P) | 2020-03-17 | 2020-03-17 | null | 02 | N | CAPECITABINE | 100255752 |
| 210003358 | 210006712 | 1.56 | 55 | Adjuvant (A) | null | 2016-08-04 | Paclitaxel+Trastuzumab wkly Maint | null | N | PACLITAXEL + TRASTUZUMAB | 100534008 |
| 210003360 | 210006714 | 1.48 | 63 | Neo-adjuvant (N) | 2019-09-07 | 2019-09-24 | FEC + DOCETAXEL | N | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101308400 |
| 210003361 | 210006715 | 1.73 | 80 | Neo-adjuvant (N) | 2016-09-06 | 2017-01-22 | ROSCO Trial | null | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100315102 |
| 210003362 | 210006716 | 1.62 | 78.7 | Neo-adjuvant (N) | null | 2018-09-05 | null | 02 | N | EC | 100603558 |
| 210003363 | 210006717 | 1.59 | 63.2 | Neo-adjuvant (N) | 2019-08-19 | 2019-09-01 | Paclitaxel+Trastuzumab wkly Maint | 02 | null | PACLITAXEL + TRASTUZUMAB | 100754558 |
| 210003364 | 210006718 | null | null | null | 2016-07-06 | 2016-07-28 | FEC + DOCETAXEL | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100922596 |
| 210003365 | 210006719 | 1.67 | 97.8 | Neo-adjuvant (N) | 2018-08-27 | 2018-08-29 | AC | 02 | N | PACLITAXEL + TRASTUZUMAB | 101816143 |
| 210003367 | 210006721 | 1.58 | 70.9 | Palliative (P) | null | 2019-03-20 | null | N | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101819454 |
| 210003370 | 210006723 | 1.62 | 77 | Neo-adjuvant (N) | 2019-10-26 | 2019-11-11 | EC | 02 | N | EC | 100300042 |
| 210003371 | 210006724 | 1.74 | 0 | Adjuvant (A) | null | 2018-03-05 | CARBOPLATIN + PACLITAXEL | null | N | PALBOCICLIB | 101027926 |
| 210003372 | 210006725 | 1.65 | 100 | Curative (C) | 2018-10-30 | 2018-11-12 | FEC 60 or 75 | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100784396 |
| 210003374 | 210006726 | 1.63 | 79.2 | Neo-adjuvant (N) | 2019-02-25 | 2019-03-10 | ROSCO Trial | 02 | N | LETROZOLE + PALBOCICLIB | 100104750 |
| 210003375 | 210006727 | 1.63 | 65.6 | Palliative (P) | null | 2018-05-06 | FEC 60 or 75 | 02 | N | FEC | 101478107 |
| 210003377 | 210006729 | 1.7 | 116.2 | null | 2017-10-20 | 2017-10-27 | Epirubicin | null | null | ROSCO TRIAL | 101866688 |
| 210003379 | 210006731 | null | 86.8 | null | 2016-10-31 | 2016-11-15 | FEC + DOCETAXEL | 02 | null | FEC + DOCETAXEL | 101641620 |
| 210003380 | 210006732 | 1.7 | 65.7 | Palliative (P) | null | 2018-09-04 | Paclitaxel+Trastuzumab wkly Maint | null | N | PACLITAXEL + TRASTUZUMAB | 100381088 |
| 210003381 | 210006733 | 1.61 | 69.3 | Palliative (P) | 2018-04-22 | 2018-05-12 | EC | null | N | EC | 101838247 |
| 210003383 | 210006734 | null | null | null | 2019-02-03 | 2019-02-05 | EC | 02 | null | EC | 101405068 |
| 210003385 | 210006735 | null | 66.3 | null | 2017-05-21 | 2017-06-03 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | 100598118 |
| 210003389 | 210006738 | null | 112 | null | 2017-03-01 | 2017-03-08 | EC | 02 | null | EC | 100808778 |
| 210003393 | 210006741 | 1.57 | 49 | null | null | 2016-12-01 | FEC 60 or 75 | N | null | FEC | 101536249 |
| 210003400 | 210006745 | null | 63.3 | null | 2017-09-27 | 2017-10-07 | Everolimus 10mg | 02 | null | LETROZOLE + PALBOCICLIB | 101441451 |
| 210003402 | 210006747 | 1.6 | 51 | null | 2019-06-29 | 2019-07-14 | FEC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101799200 |
| 210003405 | 210006750 | 1.68 | 92.5 | null | 2016-03-23 | 2016-03-31 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101204735 |
| 210003408 | 210006752 | 1.71 | 86 | Adjuvant (A) | 2019-10-04 | 2019-10-14 | EC | null | null | EC | 100432417 |